Tech Company Financing Transactions
Cyrano Therapeutics Funding Round
Cyrano Therapeutics, based in Delray Beach, raised $9 million in funding from Florida Opportunity Fund, Lumira Ventures and Remiges Ventures.
Transaction Overview
Company Name
Announced On
1/16/2024
Transaction Type
Venture Equity
Amount
$9,000,000
Round
Series B
Investors
Florida Opportunity Fund (Lead Investor)
Lumira Ventures (Lead Investor)
Remiges Ventures (Lead Investor)
Proceeds Purpose
The company intends to use the funds to advance FLAVOR, its Phase 2, double-blind, randomized clinical trial of CYR-064, an intranasal theophylline spray therapy to treat patients who have lost their sense of smell following recovery from a viral infection.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
190 Congress Park Dr. 210
Delray Beach, FL 33445
USA
Delray Beach, FL 33445
USA
Phone
Undisclosed
Website
Email Address
Overview
Cyrano Therapeutics is a private, venture-backed clinical stage regenerative medicine company. Since our foundation, we have been working diligently to develop a therapy for people struggling with the loss of smell and flavor.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Rick Geoffrion
Browse more venture capital transactions:
Prev: 1/16/2024: Ineratec venture capital transaction
Next: 1/16/2024: Trax Media venture capital transaction
Share this article
News on VC Transactions
We do our best to document every notable VC transaction. All VC database entries on this site are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs